Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome.

Trial Profile

Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Hydrochlorothiazide; Irbesartan
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Aug 2007 Status changed from in progress to completed.
    • 13 Sep 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top